Stocks
Vanda Pharmaceuticals (VNDA) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 23.5 | 12.0 | 10.3 | -4.90 | 12.5 | 6.03 | ||
| Changes by years, y/y, % | -49% | -49% | -14% | -148% | -355% | -23.0% | |||
Vanda Pharmaceuticals. EV/EBITDA
Vanda Pharmaceuticals. EV/EBITDA, changes, %
Vanda Pharmaceuticals (VNDA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -5.72 | -8.95 | -148.2 | 12.0 | 7.02 | 6.03 | |
| Changes by years, y/y, % | -173% | -186% | -1 487% | -374% | -223% | |||
| Changes by quarters, q/q, % | +31% | +57% | +1 556% | -108% | -41% | |||
